CLINICAL_TRIALS
trial_result
· 2020-05-20
Clinical Trial Update: A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer [Phase 1]
Summary
Phase 1 study evaluating olaratumab alone and with standard chemotherapies in children with cancer has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Neoplasm Metastasis | Phase 1 | Status: COMPLETED | Results posted: 2020-05-20